uniQure N.V. (QURE) — Stock Score Summary

uniQure N.V. (QURE) has a MoatMap StockRank of 6/100 based on Quality (22/100), Value (33/100), and Momentum (31/100) factor scores. The current signal is STRONG SELL. uniQure is a gene therapy developer with high cash burn and binary clinical risks that does not possess the recurring revenue, high ROIC, or CDMO gatekeeper status required for our portfolio.

uniQure N.V. is a pioneering gene therapy company dedicated to developing and commercializing transformative one-time treatments for severe genetic diseases. Leveraging its proprietary AAV gene therapy platform, the company has an approved product for hemophilia B in Europe and a robust pipeline targeting neurological and liver diseases. uniQure maintains a competitive edge through its advanced technology and integrated manufacturing capabilities.

Key Financial Metrics

Price$29.88
Market Cap$1.6B
P/E (Forward)-9.90
Price/Book8.77
Return on Equity-228.2%
Return on Invested Capital-17.2%
Debt/Equity365.37
Gross Margin0.0%
Operating Margin-1321.1%
Revenue Growth127.3%
Free Cash Flow$-104M

uniQure N.V. operates in the Biotechnology industry, part of the Healthcare sector (Netherlands).

Frequently Asked Questions

What is uniQure N.V.’s (QURE) StockRank?
MoatMap’s StockRank for uniQure N.V. (QURE) is 6/100, with a Strong Sell signal. It is a composite of Quality (22), Value (33), and Momentum (31) factor ranks across MoatMap’s 19,000+ stock universe.
Does uniQure N.V. have an economic moat?
uniQure N.V. (QURE) has a Quality factor score of 22/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is uniQure N.V. a buy, hold, or sell?
MoatMap’s current signal for uniQure N.V. (QURE) is Strong Sell, based on a StockRank of 6/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is uniQure N.V. in?
uniQure N.V. (QURE) operates in the Healthcare sector, specifically the Biotechnology industry (Netherlands).
Browse all ranked stocksQURE deep dive reportAI ChampionsHow we score stocksSense-check another stock